missing translation for 'onlineSavingsMsg'
Learn More

LY2510924, MedChemExpress

Product Code. 16481417
Encompass_Preferred
Change view
Click to view available options
Quantity:
1 mg
5 mg
10 mg
25 mg
50 mg
100 mg
Unit Size:
100mg
10mg
1mg
25mg
50mg
5mg
6 product options available for selection
Product selection table with 6 available options. Use arrow keys to navigate and Enter or Space to select.
Product Code. Quantity unitSize
16481417 50 mg 50mg
16495886 100 mg 100mg
16467927 5 mg 5mg
16443316 25 mg 25mg
16405208 10 mg 10mg
16401269 1 mg 1mg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 6 options available.
6 options
This item is not returnable. View return policy
Product Code. 16481417 Supplier Medchem Express Supplier No. HY12488
 Restricted Item
Estimated Shipment: 04-08-2026
Add to basket
Add to basket
This item is not returnable. View return policy

MedChemExpress LY2510924 is a potent and selective CXCR4 antagonist that blocks SDF-1 binding to CXCR4 with an IC50 of 0.079 nM.

LY2510924 is a potent and selective CXCR4 antagonist that blocks SDF-1 binding to CXCR4 with an IC50 of 0.079 nM.

Specifications

Chemical Name or Material LY2510924
CAS 1088715-84-7
Color White
Purity Grade Notes Research
Molecular Formula C62H88N14O10
Quantity 50 mg
Solubility Information DMSO : ≥ 125 mg/mL (105.09 mM)
SMILES O=C(NCC(N[C@H](CCC(N[C@H]1CC2=CC=CC=C2)=O)C(N[C@H](C(N)=O)CCCCNC(C)C)=O)=O)[C@@H](NC([C@@](NC([C@@H](NC([C@H](NC1=O)CC3=CC=C(O)C=C3)=O)CCCCNC(C)C)=O)([H])CCCNC(N)=N)=O)CC4=CC(C=CC=C5)=C5C=C4
Molecular Weight (g/mol) 1189.45
Formula Weight 1189.45
Percent Purity 98.0%
Grade Research
Physical Form Solid
For Use With (Application) Cancer-programmed cell death
Show More Show Less

Research purposes only

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.